Les Meilleurs doctors pour le traitement d'astrocytome en Israël - TOP-7 des médecins

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Plus de 900 interventions réalisées – Le Dr Blumental est un neuro-oncologue très expérimenté et directeur du service de neuro-oncologie au centre médical Sourasky.

• 29 ans d'expérience en oncologie
• Directeur du service de neuro-oncologie au Huntsman Cancer Institute
• Formé au Memorial Sloan-Kettering Cancer Center
• Spécialisé dans les traitements oncologiques à haut taux de réussite

Le Dr Felix Bokstein dirige la clinique de neuro-oncologie d'Ichilov, l'un des hôpitaux les plus grands et les plus avancés d'Israël, spécialisé dans les tumeurs cérébrales.

• Son activité principale porte sur le traitement des tumeurs complexes du cerveau et de la moelle épinière.
• En tant que chef de clinique, il supervise une unité dédiée à la neuro-oncologie.
• Son expérience inclut la prise en charge des gliomes, des astrocytomes et d'autres tumeurs malignes du SNC.
• Il intègre la chimiothérapie, les thérapies ciblées et les options d'essais cliniques dans les protocoles de soins.

Le professeur Zvi Ram dirige l'Association européenne des sociétés de neurochirurgie (EANS) – un rôle de haut niveau qui souligne son leadership dans le domaine.

• Se spécialiser dans la chirurgie mini-invasive et les techniques de cartographie cérébrale
• Être expert en opérations neurochirurgicales, y compris la stimulation cérébrale profonde (SCP)
• Pratiquer la neurochirurgie guidée par l'image pour les tumeurs cérébrales, formé en Grèce et en Suisse
• Diriger la recherche sur les thérapies géniques pour le cancer du cerveau
• Être honoré par le prix Borenstein de la Brain & Behavior Research Foundation

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.